Tumor necrosis factor-α -308G/A polymorphism is associated with active vitiligo vulgaris in a northeastern Mexican population

Salinas-Santander,Mauricio; Díaz-García,Daniel; Rojas-Martínez,Augusto; Cantú-Salinas,Cristina; Sánchez-Domínguez,Celia; Reyes-López,Miguel; Cerda-Flores,Ricardo  M.; Ocampo-Candiani,Jorge; Ortiz-López,Rocío

doi:10.3892/etm.2012.508

May 2012 Volume 3 Issue 5

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

May 2012 Volume 3 Issue 5

Full Size Image

Article

Tumor necrosis factor-α -308G/A polymorphism is associated with active vitiligo vulgaris in a northeastern Mexican population

Authors:
- Mauricio Salinas-Santander
- Daniel Díaz-García
- Augusto Rojas-Martínez
- Cristina Cantú-Salinas
- Celia Sánchez-Domínguez
- Miguel Reyes-López
- Ricardo M. Cerda-Flores
- Jorge Ocampo-Candiani
- Rocío Ortiz-López
View Affiliations / Copyright

Affiliations: Department of Biochemistry and Molecular Medicine, Faculty of Medicine, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico, Molecular Biology, Genomics and Sequencing Unit, Center for Research and Development in the Health Sciences, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico, Dermatology Service, Hospital Universitario ‘Dr. José Eleuterio González’, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico, Conservation Medicine, Genomics and Biotechnology Center-IPN, Cd. Reynosa, Tamaulipas, Mexico, Nursery School Faculty, Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico
Pages: 893-897
|
Published online on: March 9, 2012

https://doi.org/10.3892/etm.2012.508
Expand metrics +

Abstract

Vitiligo is a skin disease characterized by depigmentation. Its etiopathogenesis is unclear, but it has been associated with autoimmune processes. Gene polymorphisms in the tumor necrosis factor-α (TNF-α) have been associated with several imflammatory diseases. In particular, the -308G/A polymorphism in the gene promoter region has been reported to be associated with increased plasma levels of TNF-α and with an increased risk to develop autoimmune diseases. To date, this polymorphism has not been associated with vitiligo. To assess a possible association between the TNF-α -308G/A and vitiligo vulgaris (VV), 198 vitiligo patients and 395 control subjects were recruited for the study. A complete demographic and clinical profile of each case was registered to analyze the possible risk factors of vitiligo. Genomic DNA isolated from peripheral blood was subjected to PCR-RFLP for genotyping of the TNF-α -308G/A polymorphism. Causal associations were determined by χ2 test and their respective OR was assessed in a 2x2 contingency table. When population variables of type of vitiligo, gender, age of disease onset, and active disease status were considered, an association between active VV and the TNF-α GA genotype was found (P=0.0295, OR=2.0; 95% CI 1.01‑3.93). All other variables were irrelevant to vitiligo. Our data suggest a possible association between the TNF-α -308 GA genotype and the active form of VV in a Mexican population.

View Figures

View References

1.	Gauthier Y, Cario Andre M and Taïeb A: A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy? Pigment Cell Res. 16:322–332. 2003. View Article : Google Scholar : PubMed/NCBI
2.	Halder RM and Chappell JL: Vitiligo update. Semin Cutan Med Surg. 28:86–92. 2009. View Article : Google Scholar : PubMed/NCBI
3.	Shajil EM, Chatterjee S, Agrawal D, Bagchi T and Begum R: Vitiligo: pathomechanisms and genetic polymorphism of susceptible genes. Indian J Exp Biol. 44:526–539. 2006.PubMed/NCBI
4.	Zhu BC, Gao JG, Qu A, et al: A family history of vitiligo with autosomal dominant inheritance. Yi Chuan. 24:254–256. 2002.(In Chinese).
5.	Parsad D, Dogra S and Kanwar AJ: Quality of life in patients with vitiligo. Health Qual Life Outcomes. 1:582003. View Article : Google Scholar : PubMed/NCBI
6.	Spritz RA: The genetics of generalized vitiligo and associated autoimmune diseases. Pigment Cell Res. 20:271–278. 2007. View Article : Google Scholar : PubMed/NCBI
7.	Tazi-Ahnini R, McDonagh AJ, Wengraf DA, et al: The autoimmune regulator gene (AIRE) is strongly associated with vitiligo. Br J Dermatol. 159:591–596. 2008.PubMed/NCBI
8.	Rudle N: Tumor necrosis factor (TNF-α) and lymphotoxin (TNF-β). Curr Opin Immunol. 4:327–332. 1992.
9.	Spies T, Morton CC, Nedospasov SA, Fiers W, Pious D and Strominger JL: Genes for the tumor necrosis factors alpha and beta are linked to the human major histocompatibility complex. Proc Natl Acad Sci USA. 83:8699–8702. 1986. View Article : Google Scholar : PubMed/NCBI
10.	Liz-Grana M and Gomez-Reino Carnota JJ: Tumor necrosis factor. Genetics, cell action mechanism and involvement in inflammation. Alergol Inmunol Clin. 16:140–149. 2001.
11.	Yamamoto-Furusho JK, Uscanga LF, Vargas-Alarcón G, Rodríguez-Pérez JM, Zuñiga J and Granados J: Polymorphisms in the promoter region of tumor necrosis factor alpha (TNF-alpha) and the HLA-DRB1 locus in Mexican mestizo patients with ulcerative colitis. Immunol Lett. 95:31–35. 2004. View Article : Google Scholar : PubMed/NCBI
12.	Vargas-Alarcón G, Casasola-Vargas J, Rodríguez-Pérez JM, Huerta-Sil G, Pérez-Hernández N, Londoño J, Pacheco-Tena C, Cardiel MH, Granados J and Burgos-Vargas R: Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with spondyloarthritis. Hum Immunol. 67:826–832. 2006.
13.	Sánchez-Domínguez CN, Buenfil-Lozano JA, Molina-Guajardo CA, Borjas-Almaguer OD, Castillo-Lartigue A, Bustamante-Sáenz A, Martínez-Rodríguez HG, Alarcón MA, Reyes-López MA and Ortiz-López R: Frequency of S and Z alleles for alpha-1-antitrypsin and tumor necrosis factor alpha -308 promoter polymorphism in northeastern Mexico. Allergy Asthma Proc. 29:406–410. 2008.PubMed/NCBI
14.	Hernández-Pacheco G, Flores-Domínguez C, Rodríguez-Pérez JM, Pérez-Hernández N, Fragoso JM, Saul A, Alvarez-León E, Granados J, Reyes PA and Vargas-Alarcón G: Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with rheumatic heart disease. J Autoimmun. 21:59–63. 2003.PubMed/NCBI
15.	Martínez-Ríos MA, Peña-Duque MA, Fragoso JM, Delgadillo-Rodríguez H, Rodríguez-Pérez JM, Miranda-Malpica E, Cruz-Robles D, Cavazos-Quero MM, Rodríguez-Lobato LG and Vargas-Alarcón G: Tumor necrosis factor alpha and interleukin 10 promoter polymorphisms in Mexican patients with restenosis after coronary stenting. Biochem Genet. Jul 8–2009.(E-pub ahead of print).
16.	Namian AM, Shahbaz S, Salmanpoor R, Namazi MR, Dehghani F and Kamali-Sarvestani E: Association of interferon-gamma and tumor necrosis factor alpha polymorphisms with susceptibility to vitiligo in Iranian patients. Arch Dermatol Res. 301:21–25. 2009. View Article : Google Scholar : PubMed/NCBI
17.	Yazici AC, Erdal ME, Kaya TI, Ikizoglu G, Savasoglu K, Camdeviren H and Tursen U: Lack of association with TNF-alpha-308 promoter polymorphism in patients with vitiligo. Arch Dermatol Res. 298:46–49. 2006. View Article : Google Scholar : PubMed/NCBI
18.	Chen YP, Pfab T, Slowinski T, Richter CM, Godes M and Hocher B: Impact of genetic variation of tumor necrosis factor-α on gestational hypertension. Chin Med J (Engl). 119:719–724. 2006.
19.	Huang CL, Nordlund JJ and Boissy R: Vitiligo: a manifestation of apoptosis? Am J Clin Dermatol. 3:301–308. 2002. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Tumor necrosis factor-α -308G/A polymorphism is associated with active vitiligo vulgaris in a northeastern Mexican population

This article is mentioned in:

Abstract

Related Articles